NO882226L - Fibrinolytiske proteiner. - Google Patents

Fibrinolytiske proteiner.

Info

Publication number
NO882226L
NO882226L NO882226A NO882226A NO882226L NO 882226 L NO882226 L NO 882226L NO 882226 A NO882226 A NO 882226A NO 882226 A NO882226 A NO 882226A NO 882226 L NO882226 L NO 882226L
Authority
NO
Norway
Prior art keywords
fibrinolytic proteins
fibrinolytic
proteins
Prior art date
Application number
NO882226A
Other languages
English (en)
Other versions
NO882226D0 (no
Inventor
Eileen R Mulvihill
Donald C Foster
Patrick J O'hara
Anur Ashok Kumar
Donald D Rao
Margaret Y Insley
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO882226D0 publication Critical patent/NO882226D0/no
Publication of NO882226L publication Critical patent/NO882226L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO882226A 1987-05-22 1988-05-20 Fibrinolytiske proteiner. NO882226L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5341187A 1987-05-22 1987-05-22

Publications (2)

Publication Number Publication Date
NO882226D0 NO882226D0 (no) 1988-05-20
NO882226L true NO882226L (no) 1988-11-23

Family

ID=21984041

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882226A NO882226L (no) 1987-05-22 1988-05-20 Fibrinolytiske proteiner.

Country Status (7)

Country Link
EP (1) EP0292009A1 (no)
JP (1) JPS6463379A (no)
KR (1) KR880013978A (no)
AU (1) AU626147B2 (no)
DK (1) DK275788A (no)
FI (1) FI882407A7 (no)
NO (1) NO882226L (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079159A (en) * 1983-12-27 1992-01-07 Genetics Institute, Inc. Method for making tissue plasminogen activator
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
WO1993012225A1 (en) * 1991-12-16 1993-06-24 Genentech, Inc. Novel tissue plasminogen activator variants
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
DK0462207T3 (da) * 1989-03-06 2001-06-18 Univ Texas t-Pa mutanter resistente mod deres respektive inhibitorer
US5550042A (en) * 1989-03-06 1996-08-27 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
DE69215537T2 (de) * 1991-12-16 1997-04-30 Genentech, Inc., South San Francisco, Calif. t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT
DE69333127T2 (de) * 1992-06-03 2004-05-06 Genentech, Inc., South San Francisco Varianten des Gewebeplasminogenaktivators mit verbesserter therapeutischer Wirkung
ATE386811T1 (de) 1996-04-05 2008-03-15 Novartis Vaccines & Diagnostic Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
US7176013B2 (en) * 2003-06-11 2007-02-13 Schering Aktiengesellschaft Modified corin molecules having substitute activation sequences and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
AU596356B2 (en) * 1985-04-22 1990-05-03 Genentech Inc. Novel human tissue plasminogen activator mutants
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
DK623186A (da) * 1985-12-23 1987-08-26 Chiron Corp Polypeptid med vaevsplasminogen-aktivator-virkning
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
JP2527454B2 (ja) * 1986-01-31 1996-08-21 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質
GB8608020D0 (en) * 1986-04-02 1986-05-08 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
FI882407L (fi) 1988-11-23
JPS6463379A (en) 1989-03-09
DK275788D0 (da) 1988-05-20
DK275788A (da) 1989-02-03
FI882407A7 (fi) 1988-11-23
FI882407A0 (fi) 1988-05-20
AU1652888A (en) 1988-11-24
AU626147B2 (en) 1992-07-23
NO882226D0 (no) 1988-05-20
KR880013978A (ko) 1988-12-22
EP0292009A1 (en) 1988-11-23

Similar Documents

Publication Publication Date Title
FI884993L (fi) Polypeptider.
NO883910L (no) Kompressor.
FI884201A0 (fi) Ljussignalanordning.
FI872341A0 (fi) Anordning foer hyttelement.
NO881658L (no) Biofunksjonelle proteiner.
FI882407A7 (fi) Fibrinolyyttisiä proteiinejä.
FI882283L (fi) Proteiner med tnf-verkan.
FI902294A0 (fi) Blodtagningsanordning.
FI880697A0 (fi) Manoeverdon foer elektriskt block.
FI873345A0 (fi) Laosanordning.
NO881384L (no) Peptider.
NO885108D0 (no) Peptider.
FI871559L (fi) Isbrytare.
FI900587A0 (fi) Kross- eller malelement foer trumraffinoer.
FI880738A0 (fi) Televisionssaendningssystem.
FI900108A0 (fi) Elledning.
FI883943L (fi) Modifierade plasminogen-aktivatorer.
FI900354A0 (fi) En trafikmedel flyttande anordning.
FI871077L (fi) Elplatta.
FI885712A0 (fi) Valsmagasin.
FI891780A0 (fi) Kontinuerligt fungerande straengpressningsanordning.
FI893879A7 (fi) Blandnings- och utfaellningsanordning foer vaetske-vaetskeextrahering.
FI891116A0 (fi) Transportoerrullkonstruktion.
FI871686A0 (fi) Matarsystem foer kontinuerlig elkraft.
FI885621L (fi) Styrkoppling foer gto-tyristorer.